Notification Text

OncoStrands® Promoter Methylation

Specimen Requirements
Clinical usagePCR-based methylation tests are used to inform and help predict patient outcomes, as well as serve as a guide for preventive measures, such as surveillance and risk reduction strategies, in individuals with an increased risk of developing cancer.

– MLH1: Detection of methylation of the MLH1 gene promoter on FFPE, adjunct to MSI, MMR IHC, and for colon or endometrial tumours demonstrating MSI-H and loss of MLH1 protein expression.
– MGMT: Detection of methylation of MGMT gene promoter on FFPE, for prognostic and predictive value for glioblastoma patients.
Type of sample– Formalin-fixed paraffin-embedded (FFPE) Tissue/Cell Block (preferred) or
– 10 x 5µm unstained slides of FFPE tissue mounted on uncoated slides + 1 H&E stained slide
– 10 x 5µm normal tissue slides (If available for MLH1 promoter methylation test)
Surface Area & Tumour PurityMinimum surface area of 5 x 5 mm2 per slide. If the tissue area is smaller, please provide additional 5-10 5µm unstained slides. At least 10% tumour purity per slide.
Storage & transportationPlease keep at room temperature. Do not freeze, and keep away from direct sunlight.
Turnaround Time (TAT)12 working days (No additional day if add-on)
At DNA LAB, we offer reference functions in molecular diagnostic and screening services for most Obstetricians, Gynaecologist, Paediatrics, Clinical Oncologists, GP Clinics, medical centres and hospitals in Malaysia.

FAQ